SnackableHealth™ | Finer points from “FINEARTS”: non-steroidal MRA across HFmrEF - HFpEF—consistent benefit and pragmatic safety
Drs. James Januzzi and Scott Solomon discuss how the FINEARTS study expands the role of non-steroidal MRAs in HFmrEF and HFpEF, combining efficacy with practical safety.
Medical Affairs
7 min read
December 15, 2025
Cardiology
Highlights
Medical Affairs
Trastuzumab deruxtecan (T-DXd) Provides Significant Clinical Benefit Over Trastuzumab emtansine (T-DM1), Marking a Potential Shift in the Therapeutic Standard for HER2+ Breast Cancer
TribeMD
SnackableHealth™ | From Intervention to Prevention: How Secondary Prevention Clinics Are Redefining Post-ACS Care
Medical Affairs
META-AF: Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation
Medical Affairs
Trastuzumab deruxtecan (T-DXd) Provides Significant Clinical Benefit Over Trastuzumab emtansine (T-DM1), Marking a Potential Shift in the Therapeutic Standard for HER2+ Breast Cancer
TribeMD
SnackableHealth™ | From Intervention to Prevention: How Secondary Prevention Clinics Are Redefining Post-ACS Care
Medical Affairs
META-AF: Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation